Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Vumerity, diroximel fumarate, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 15/11/2021, Revision: 4, Status: Authorised
TO: